Richard Koppes

Richard Koppes is a declared insider at 3 companies; the most frequent names are Valeant Pharmaceuticals International, Apria Healthcare Group Inc and RiceBran Technologies. The record holds 32 filings, for trades running from 30 March 2006 to 28 September 2011.

The open-market side counts 2 purchases for €30k alongside 4 sales for €172k. Taken together, the sales exceed the purchases by €142k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 22 share grants and 2 option exercises. Since January 2011: 1 purchase and no sales on the market.

Most recently, on 29 September 2011, the filings show a share grant worth €11k in RiceBran Technologies. The latest purchase dates back some time: it was published 5,503 days ago, on 29 September 2011. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.